πŸ‡ΊπŸ‡Έ FDA
Patent

US 10654850

Pyridazinones and methods of use thereof

granted A61PA61P13/12A61P25/04

Quick answer

US patent 10654850 (Pyridazinones and methods of use thereof) held by Goldfinch Bio, Inc. expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Goldfinch Bio, Inc.
Grant date
Tue May 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P13/12, A61P25/04, A61P25/22, A61P25/24